5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.26▲ | 6.22▲ | 6.11▲ | 5.91▲ | 5.76▲ |
MA10 | 6.16▲ | 6.08▲ | 6.01▲ | 5.83▲ | 5.60▲ |
MA20 | 6.02▲ | 5.95▲ | 5.88▲ | 5.52▲ | 6.13▲ |
MA50 | 5.89▲ | 5.84▲ | 5.77▲ | 5.53▲ | 9.69▼ |
MA100 | 5.78▲ | 5.62▲ | 5.51▲ | 6.30▼ | 12.71▼ |
MA200 | 5.62▲ | 4.59▲ | 3.07▲ | 9.15▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.031▲ | 0.038▲ | 0.038▲ | 0.094▲ | 0.301▲ |
RSI | 68.971▲ | 68.101▲ | 71.289▲ | 63.256▲ | 40.802▼ |
STOCH | 94.185▲ | 86.855▲ | 80.409▲ | 74.378 | 32.984 |
WILL %R | -3.448▲ | -3.409▲ | -3.409▲ | -1.288▲ | -66.610 |
CCI | 81.667 | 117.923▲ | 180.284▲ | 162.872▲ | 33.668 |
Wednesday, June 29, 2022 11:33 PM
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 149.3% to $1.56 in pre-market trading after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for ...
|
Wednesday, June 29, 2022 10:38 PM
AIkido Pharma Inc. (NASDAQ:AIKI – Get Rating Shares of NASDAQ:AIKI opened at $5.79 on Thursday. AIkido Pharma has a 12 month low of $4.30 and a 12 month high of $17.17. The company’s fifty day ...
|
Wednesday, June 29, 2022 10:38 PM
AIkido Pharma Inc. (NASDAQ:AIKI – Get Rating) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 59,900 shares, a growth of ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
05/07/22 | 5.93 | 6.285 | 5.93 | 6.27 | 85,137 |
01/07/22 | 5.90 | 6.09 | 5.83 | 5.99 | 106,201 |
30/06/22 | 5.64 | 5.97 | 5.57 | 5.90 | 95,000 |
29/06/22 | 5.6399 | 5.82 | 5.48 | 5.79 | 82,475 |
28/06/22 | 5.969 | 5.99 | 5.57 | 5.62 | 50,390 |
27/06/22 | 5.78 | 6.14 | 5.76 | 5.96 | 79,000 |
24/06/22 | 5.71 | 5.89 | 5.64 | 5.84 | 62,000 |
23/06/22 | 5.81 | 5.93 | 5.40 | 5.66 | 144,333 |
22/06/22 | 5.55 | 5.9199 | 5.48 | 5.74 | 144,344 |
21/06/22 | 5.47 | 5.76 | 5.37 | 5.57 | 134,300 |
|
|
||||
|
|
||||
|
|